US Pharma MarketingKenvue’s Tylenol with Naproxen gains FDA approval
Kenvue’s Tylenol with Naproxen gains FDA approval is a pharma and life sciences industry update from Pharmaceutical Technology. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
The FDA has approved Kenvue’s Tylenol with Naproxen, the first OTC fixed-dose combination of acetaminophen and naproxen sodium.
Source: Pharmaceutical Technology